M. Ashworth

Management of a patient with advanced BRAF-mutant melanoma.

A. Daud, M. Ashworth, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

Phase I dose-escalation trial of checkpoint kinase 1 inhibitor MK-8776 as monotherapy and in combination with gemcitabine in patients with advanced solid tumors.

A. Venook, P. Munster, A. Daud, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Granulomatous endometritis following hysteroscopic resection of the endometrium

W. Kenyon, M. Ashworth, C. Moss, 1991, Histopathology.

Melanoma immunotherapy

A. Daud, M. Rosenblum, P. Quaglino, 2014, Cancer biology & therapy.

Characteristics of pyrexia in BRAF V 600 E / K metastatic melanoma patients treated with combined dabrafenib and trametinib in a phase I / II clinical trial

K. Flaherty, J. Sosman, J. Infante, 2015 .

Characteristics of pyrexia in BRAFV600E/K metastatic melanoma patients treated with combined dabrafenib and trametinib in a phase I/II clinical trial.

K. Flaherty, J. Sosman, J. Infante, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Systemic antitumor effect and clinical response in a phase 2 trial of intratumoral electroporation of plasmid interleukin-12 in patients with advanced melanoma.

R. Pierce, A. Daud, L. Fong, 2014 .

with combined dabrafenib and trametinib in a phase 1/2 clinical trial

K. Flaherty, J. Sosman, S. Swann, 2014 .

Combinatorial approach to treatment of melanoma.

A. Daud, M. Ashworth, 2014, Hematology/oncology clinics of North America.

Human papillomavirus in squamous cell carcinoma of the oesophagus associated with tylosis.

M. Ashworth, S. Southern, J. Nash, 1993, Journal of clinical pathology.